P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION. Issue 2 (15th March 2018)